Recently, numerous studies have substantiated that both STAT3 and the EMT are closely related to the initiation and development of malignant tumours [35–37], and the STAT3 protein has the potential to become an ideal drug target for anti-tumour therapy. The gene discussed is STAT3; the disease is cancer.